Pune, India, July 25, 2023 (GLOBE NEWSWIRE) -- The global sexually transmitted diseases testing market size was valued at USD 8.80 billion in 2022. The market is projected to grow from USD 9.52 billion in 2023 to USD 16.68 billion by 2030, exhibiting a CAGR of 8.3% during the forecast period.
Sexually Transmitted Diseases (STDs) are infections caused by viruses, parasites, or bacteria, which are transmitted through sexual contact, including oral sex, vaginal, and anal. It may also get transmitted vertically, that is, from mother to child, during breastfeeding, childbirth, and pregnancy.
Fortune Business Insights™ mentioned this in a report titled “Sexually Transmitted Diseases Testing Market, 2023-2030.”
Request a Free Sample PDF:
Key Industry Developments:
- August 2022: Thermo Fisher Scientific Inc. launched Applied Biosystems HIV-1 Genotyping Kit that detects drug-resistant strains of HIV-1.
Key Takeaways:
- Regulatory scenario for key countries
- Pipeline analysis
- Technological advancements in sexually transmitted diseases devices
- Prevalence of sexually transmitted diseases by key countries
- PESTEL analysis
- Recent industry developments such as partnerships, mergers, and acquisitions
- Overview of new product launches in sexually transmitted diseases testing
List of Key Players Present in the Report:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott (U.S.)
- BD (U.S.)
- Hologic, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- bioMerieux, Inc. (France)
- Cepheid (Danaher Corporation) (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- DiaSorin S.p.A (Italy)
COVID-19 Impact-
Decrease in Number of Reported Cases during COVID-19 Impacted the Market Growth Adversely
The sudden outbreak of the pandemic has impacted the market adversely owing to a decrease in STD testing, which accounted for an increase in underreported cases and an increase in transmission of these diseases. The prominent players in the market witnessed a decrease in their segmental revenue growth in FY 2020, owing to the outbreak of the novel COVID-19 pandemic.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:
Drivers & Restraints-
Rising Incidence of Sexually Transmitted Diseases to Propel the Market Growth
The increasing incidence of STDs is predicted to surge the demand for sexually transmitted diseases testing kits and instruments, especially in emerging countries. Some of the other factors responsible, such as sharing sex toys, lack of focus on safer sexual intercourse methods, and sharing of needles or equipment for injecting drugs or steroids, are growing the risk of sexually transmitted diseases.
The absence of knowledge of providers and limited counseling skills are leading to a rise in the undiagnosed population suffering from these diseases globally. Also, a large population group is reluctant toward testing owing to obstacles such as perceived stigma related to STIs and confidentially.
Segments-
Kits & Reagents Segment Held the Market Owing to Rising Demand in 2022
On the basis of product type, the market is segmented into instruments and kits & reagents. The kits & reagents segment held the largest share to dominate the market. The growth is mainly attributed to the increasing incidence of sexually transmitted infections, which will surge the number of patients undergoing testing.
Growing Incidences of Chlamydia Dominated the Segment in 2022
Based on application, the market is divided into chlamydia, syphilis, genital herpes, gonorrhea, human immunodeficiency virus, human papillomavirus, and others. Chlamydia recorded the largest share of the global market in 2022. The growing incidence rate is attributed to rising awareness, which is growing the diagnosis rate of this disease.
Greater Preference for Laboratory Testing to Dominate the Market Share
According to setting, the market is bifurcated into point-of-care testing and laboratory testing. The laboratory testing segment held the largest share of the segment to dominate the global market in 2022. Laboratory testing or lab-based testing is a traditionally preferred model for testing due to its accuracy compared to point-of-care. The point-of-care segment is expected to escalate at the highest CAGR during the projected period.
Quick Buy - Sexually Transmitted Diseases Testing Market Research Report:
https://www.fortunebusinessinsights.com/compare-plan/101095
Rise in Patient Visits Led to the Dominance of the Diagnostic Centers Segment in 2022
As per end user, the market is divided into diagnostic centers, hospitals & clinics, and others. The diagnostic centers segment dominated the global market in 2022. The segment dominated the sexually transmitted diseases testing market share owing to increasing number of patient visits in laboratories and the availability of advanced instruments with well-trained professionals.
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Report Coverage-
The report offers:
- Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
- Comprehensive insights into regional developments.
- List of major industry players.
- Key strategies adopted by the market players.
- Latest industry developments such as product launches, partnerships, mergers, and acquisitions.
Regional Insights-
North America Dominated the Market Owing to Rising Awareness of Diseases
The North America sexually transmitted diseases testing market growth is attributed to the growing awareness of the diseases. The increasing adoption rate of products indulged in these disease testing is anticipated to grow during the projected period.
The Europe market is predicted to grow with subsequent CAGR during the projected period. The growth in this region is attributed to the availability of advanced instruments and equipment required for testing with well-trained professionals.
Competitive Landscape-
Active R&D Investment and Robust Distribution Channels to Drive the Market Growth
The global market is fragmented with many global and domestic sexually transmitted diseases testing players offering a wide range of products for various indications. The tier 1 companies consist of bioMerieux Inc., Abbott, and Bio Rad Laboratories Inc., who account for a significant proportion of the global market.
Ask for Customization of this Report:
Table Of Contents :
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Prevalence of Key Diseases, By Key Countries, 2022
- Key Industry Developments
- Overview of Regulatory Scenario, By Key Countries/Regions
- Technological Advancements in Sexually Transmitted Diseases Testing Market
- Impact of COVID-19 on Global Sexually Transmitted Diseases Testing Market
- Global Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- Market Analysis, Insights and Forecast – By Product Type
- Instruments
- Reagents & Kits
- Market Analysis, Insights and Forecast – By Application
- Chlamydia
- Syphilis
- Genital Herpes
- Gonorrhea
- Human Immunodeficiency Virus
- Human Papillomavirus (HPV)
- Others
- Market Analysis, Insights and Forecast – By Setting
- Laboratory Testing
- Point-of Care (POC)
- Market Analysis, Insights and Forecast – By End User
- Hospitals and Clinics
- Diagnostic Centers
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market Analysis, Insights and Forecast – By Product Type
- North America Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- Market Analysis, Insights and Forecast – By Product Type
- Instruments
- Reagents & Kits
- Market Analysis, Insights and Forecast – By Application
- Chlamydia
- Syphilis
- Genital Herpes
- Gonorrhea
- Human Immunodeficiency Virus
- Human Papillomavirus (HPV)
- Others
- Market Analysis, Insights and Forecast – By Setting
- Laboratory Testing
- Point-of Care (POC)
- Market Analysis, Insights and Forecast – By End User
- Hospitals and Clinics
- Diagnostic Centers
- Others
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
- Market Analysis, Insights and Forecast – By Product Type
Toc Continue..
FAQs :
What are the key factors driving the market?
- The rising incidence of sexually transmitted diseases and shifting preference toward point-of-care testing are some of the major factors driving the global market.
How big is the STD testing market?
- The global Sexually Transmitted Diseases Testing Market size was valued at USD 8.80 billion in 2022. The market is projected to grow from USD 9.52 billion in 2023 to USD 16.68 billion by 2030, exhibiting a CAGR of 8.3% during the forecast period.
Related Reports:
Real World Evidence Solutions Market Size, Share, Revenue Forecast and Opportunities
Orthokeratology Lens Market Overview, Industry Share and Forecast
Flow Cytometry Market Size, Share, Opportunities & Analysis
Artificial Intelligence (AI) in Healthcare Market Analysis, Global Size and Industry Share Forecast
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
